Confirmed Sponsors & Exhibitors
We would like to thank all our sponsors for their support at EAONO WEEK 2021
Please remember to take some time to view their content on the virtual event platform!
Advanced Bionics is a global leader in developing hearing solutions for individuals with severe-to-profound hearing loss who no longer benefit from hearing aids. Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB develops cutting-edge cochlear implant technology that allows recipients to hear their best. AB joined Phonak as part of the Sonova Group of companies and began a collaboration unlike any other in the industry. Since then, the innovation leaders in cochlear implants and hearing aids have continuously combined technologies to deliver new, unequalled hearing solutions.
With sales in more than 50 countries and a proven track record for developing high-performing, state-of-the-art products, AB’s talented worldwide group of technologists and professionals are driven to engage with patients and professionals, work with integrity, and stay firmly committed to the best possible performance.
Advanced Bionics provides a comprehensive range of products designed to meet your patients’ needs and lifestyle. Our cochlear implant system (CI) offers more ways to hear than any other CI. And every aspect of our CI has been optimised for clarity, comfort, ease of use, and reliability—allowing your patients to hear their best.
About Cochlear Limited (ASX: COH) Cochlear is the global leader in implantable hearing solutions with products including cochlear implants, bone conduction implants and acoustic implants. Cochlear commenced operations in 1981 as part of the Nucleus group and in 1995 listed on the Australian Securities Exchange (ASX). Today, Cochlear is a Top 50 ASX-listed company with annual global revenues of AUD$1.4 billion.
Cochlear aims to support cochlear implantation becoming the standard of care for people with severe to profound hearing loss. Cochlear also provides bone conduction implants for people with conductive hearing loss, mixed hearing loss and single sided deafness. Cochlear has provided more than 600,000 implantable devices, helping people of all ages to hear. Whether these hearing solutions were implanted today or many years ago, Cochlear strives to continuously develop new technologies and innovations for all recipients. Cochlear invests more than AUD$180 million each year in research and development and currently participates in over 100 collaborative research programs worldwide.
Cochlear’s global headquarters are on the campus of Macquarie University in Sydney, Australia with regional headquarters in Asia Pacific, Europe and the Americas. Cochlear has a significant international footprint, selling in over 180 countries, and a global workforce of more than 4,000 employees.
Cochlear strives to help people hear – aiming to provide them with a lifetime of hearing through the best possible support.
Hear now. And always
MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by a mission to overcome hearing loss as a barrier to communication. The Austrian-based, privately owned business was co-founded by industry pioneers Ingeborg and Erwin Hochmair, whose ground-breaking research led to the development of the world’s first micro-electronic multi-channel cochlear implant (CI), which was successfully implanted in 1977 and was the basis for what is known as the modern CI today. This laid the foundation for the successful growth of the company in 1990, when they hired their first employees. To date, MED-EL has grown to more than 2,200 employees from around 75 nations and has 30 locations worldwide.
The company offers the widest range of implantable and non-implantable solutions to treat all types of hearing loss, enabling people in 124 countries enjoy the gift of hearing with the help of a MED-EL device. MED-EL’s hearing solutions include cochlear and middle ear implant systems, a combined Electric Acoustic Stimulation hearing implant system, auditory brainstem implants as well as surgical and non-surgical bone conduction devices.
Oticon Medical is a global company in implantable hearing solutions, dedicated to bringing the magical world of sound to people at every stage of life. As a member of one of the world’s largest groups of hearing health care companies, we share a close link with Oticon and direct access to the latest advancements in hearing research and technologies. Our competencies span more than a century of innovations in sound processing and decades of pioneering experience in hearing implant technology.
By working collaboratively with patients, physicians and hearing care professionals, we ensure that every solution we create is designed with user needs in mind. We share an unwavering commitment to provide innovative solutions and support that enhance quality of life for people wherever life may take them. Because we know how much sound matters.
KURZ is one of the world’s leading manufacturers of middle ear prostheses in Titanium and Nitinol. KURZ covers the entire range of implants required for tympanoplasty and stapedioplasty. In addition, the product line is rounded off by precision otological instruments and ventilation tubes.
KURZ prostheses are available in numerous types and offer ideal solutions also in challenging anatomical situations.
In our developmental efforts, we work closely with leading national and international scientists, surgeons and engineers. Based on science and clinical evidence KURZ provides the most advanced Middle Ear reconstruction systems.
Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical, Surgical, Neurotechnology and Spine that help improve patient and hospital outcomes.
Our neuro and otology surgical products are part of Stryker’s broader neurotechnology portfolio. We focus on delivering the high-performance instrumentation needed for complex procedures in the most delicate and complex areas of the human body.
Making healthcare better is our priority, and we believe medical technology can play an even greater role in improving people’s lives. With challenges facing families and healthcare systems — such as rising costs, aging populations, and the burden of chronic disease — we are using the power of technology to take healthcare Further, Together.
Innovation and collaboration are central to who we are. Since the late 1940s, we have been working with others to alleviate pain, restore health, and extend life. Today, we are a medical technology leader, employing more than 84,000 people worldwide, and offering therapies and solutions that enable greater efficiency, access, and value — for healthcare systems, providers, and the people they serve. Learn more at www.medtronic.eu.